Page last updated: 2024-08-26

1-methyltryptophan and Colitis Gravis

1-methyltryptophan has been researched along with Colitis Gravis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Dai, W; He, B; Wang, S; Wang, X; Wu, P; Yang, L; Yao, S; Zhang, H; Zhang, Q	1

Other Studies

1 other study(ies) available for 1-methyltryptophan and Colitis Gravis

Article	Year
Oral administration of nanoformulated indoximod ameliorates ulcerative colitis by promoting mitochondrial function and mucosal healing. International journal of pharmaceutics, 2023, Apr-25, Volume: 637 Topics: Administration, Oral; Animals; Caco-2 Cells; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Humans; Inflammation; Intestinal Mucosa; Mice; Mice, Inbred C57BL; Mitochondria	2023

Article

Year

Oral administration of nanoformulated indoximod ameliorates ulcerative colitis by promoting mitochondrial function and mucosal healing.

International journal of pharmaceutics, 2023, Apr-25, Volume: 637

Topics: Administration, Oral; Animals; Caco-2 Cells; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Humans; Inflammation; Intestinal Mucosa; Mice; Mice, Inbred C57BL; Mitochondria

2023